BATTLE OF THE BULGE: Musk and RFK Jr. on collision course over weight loss drugs
Elon Musk and Robert F. Kennedy Jr. are on a collision course in a heated debate over the efficacy and safety of certain weight loss drugs.
The Tesla CEO and the environmental lawyer have been at odds on social media, with Musk touting the benefits of Alli, an over-the-counter weight loss supplement that contains orlistat, a prescription medication used to treat obesity.
RFK Jr. has been a vocal critic of the drug, linking it to liver damage, kidney disease, and other health complications. He has also accused Musk of being “reckless and irresponsible” for promoting the product to his massive followers on Twitter.
Musk fired back, calling RFK Jr. “a con artist” and “a snake oil salesman,” accusing him of spreading misinformation about the drug. He also claimed that the scientific evidence supports the safety and effectiveness of Alli, and that it has been approved by regulatory agencies around the world.
The feud has sparked a heated debate online, with many fans siding with Musk and others backing RFK Jr.’s concerns. The pharmaceutical industry has also been forced to weigh in, with some experts arguing that Alli is a safe and effective tool for helping people achieve a healthy weight.
As the battle of the bulge rages on, one thing is clear: the public is being bombarded with vastly different messages about the safety and efficacy of weight loss drugs. In the end, it’s up to individuals to do their own research and consult with their doctors before making any decisions about their health.